Daisuke Hasegawa

33PUBLICATIONS
190CO-AUTHORS
Adolescent healthMolecular targetsHaematological tumoursInfant and child healthRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|May 25, 2026
Clinical Characteristics and Outcomes of Acute Megakaryoblastic Leukemia With t(1;22)(p13;q13) in Children.

|Mar 25, 2026
Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022.

Yoshiaki Kinoshita, Kosuke Ishikawa, Sadanori Akita

|Mar 06, 2026
Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Danika Di Giacomo, Petri Pölönen, Valentina Bardelli

|Mar 06, 2026
BCL11B enhancer hijacking by t(14;16)(q32;q24) translocation defines a novel high-risk subtype of T-ALL.

Kaito Mimura, Akira Kaino, Yotaro Ochi

|Feb 25, 2026
Combined Tyrosine Kinase Inhibitors and Chemotherapy Based on Minimal Residual Disease in Children With Ph+ Acute Lymphoblastic Leukemia: A Phase 2 Single-Arm Trial, JCCG ALL-Ph13.

Atsushi Sato, Yuichi Kodama, Hirohide Kawasaki

|Apr 28, 2025
Pain Assessment Tools for Infants, Children, and Adolescents With Cancer: Protocol for a Scoping Review.

Mika Hirata, Noyuri Yamaji, Shotaro Iwamoto

Pageof 6

Frequent Collaborators

7 joint publications

Shotaro Iwamoto

7 joint publications

Takashi Taga

7 joint publications

Daisuke Tomizawa

6 joint publications

Asahito Hama